Michael Ringel
Managing Director & Senior Partner
Boston
Michael Ringel is Boston Consulting Group's global leader for innovation analytics and research and product development, and is a core member of the firm’s Corporate Finance & Strategy practice.
Since joining the firm in 1999, Michael has worked with biotech and pharmaceutical clients on topics such as disease area strategy, transformation and process optimization, sourcing and partnerships, and organization design. He also has extensive experience in mergers and acquisitions, licensing strategy, valuation, and post-merger integration.
Michael is a frequent contributor to industry journals, including Nature Reviews Drug Discovery, and has coauthored numerous BCG reports on innovation, R&D, and corporate strategy. He sits on the board of The Nature Conservancy in Massachusetts.
Before joining BCG, Michael worked in academia, investigating theoretical population dynamics and conducting field research in the Amazon basin near Manaus, Brazil.
The Middle East is home to some of the most committed innovators in the world.
Consistency is key. Winners back up their ambition with investment.
Innovation is hard. Serial innovation is harder. What does it take to keep winning?
In challenging times, innovation is more important than ever. Here are six moves to help you navigate the crisis and build the foundation to win the recovery.
Machine learning can make it much easier to determine the probability of a startup’s success.
New technologies are transforming the pharmaceutical industry’s approach to R&D. What’s happening now in the field—and what’s coming next?
What are the key trends—and which companies do executives see as this year’s 50 most innovative?
Innovation executives view AI as an increasingly important source of efficiency and differentiation. But among average innovators, less than 10% see themselves as above average on AI.
Increasingly, innovation is a team effort, with organizations embracing external partners to create products, services, and business models they couldn’t do on their own.
